Cara A. Timpani

1.1k total citations
34 papers, 803 citations indexed

About

Cara A. Timpani is a scholar working on Molecular Biology, Physiology and Rehabilitation. According to data from OpenAlex, Cara A. Timpani has authored 34 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Physiology and 10 papers in Rehabilitation. Recurrent topics in Cara A. Timpani's work include Muscle Physiology and Disorders (20 papers), Exercise and Physiological Responses (10 papers) and Cancer Treatment and Pharmacology (6 papers). Cara A. Timpani is often cited by papers focused on Muscle Physiology and Disorders (20 papers), Exercise and Physiological Responses (10 papers) and Cancer Treatment and Pharmacology (6 papers). Cara A. Timpani collaborates with scholars based in Australia, Switzerland and United States. Cara A. Timpani's co-authors include Emma Rybalka, Alan Hayes, Nuri Gueven, Dean G. Campelj, Matthew B. Cooke, Dirk Fischer, Andrew D. Williams, Kulmira Nurgali, Judy B. de Haan and Craig A. Goodman and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Cara A. Timpani

33 papers receiving 795 citations

Peers

Countries citing papers authored by Cara A. Timpani

Since Specialization

Citations

This map shows the geographic impact of Cara A. Timpani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara A. Timpani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara A. Timpani more than expected).

Fields of papers citing papers by Cara A. Timpani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara A. Timpani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara A. Timpani. The network helps show where Cara A. Timpani may publish in the future.

Co-authorship network of co-authors of Cara A. Timpani

This figure shows the co-authorship network connecting the top 25 collaborators of Cara A. Timpani. A scholar is included among the top collaborators of Cara A. Timpani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cara A. Timpani. Cara A. Timpani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy 2025 ·Redox Biology ·(unknown), Cara A. Timpani, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Xu Yan, Jujiao Kuang, (unknown), Judy B. de Haan, Deanna Deveson Lucas, Nicole Stupka, Dirk Fischer, Emma Rybalka	1
2	Loss of endogenous estrogen alters mitochondrial metabolism and muscle clock‐related protein Rbm20 in female mdx mice 2024 ·The FASEB Journal ·Cara A. Timpani, (unknown), (unknown), (unknown), Luke E. Formosa, Joel R. Steele, (unknown), Ralf B. Schittenhelm, Aaron P. Russell, Emma Rybalka, Angus Lindsay	4
3	Dimethyl fumarate modulates the dystrophic disease program following short-term treatment 2023 ·JCI Insight ·Cara A. Timpani, (unknown), (unknown), Dean G. Campelj, (unknown), Narges Dargahi, (unknown), (unknown), (unknown), (unknown), (unknown), Nicole Stupka, Patricia Hafner, Peter G. Arthur, Jessica R. Terrill, Vasso Apostolopoulos, Judy B. de Haan, (unknown), Dirk Fischer, Emma Rybalka	6
4	FKBP25 regulates myoblast viability and migration and is differentially expressed in in vivo models of muscle adaptation 2023 ·FEBS Journal ·(unknown), (unknown), Cara A. Timpani, Emma Rybalka, John T. Price, Craig A. Goodman	1
5	Adenylosuccinic Acid: An Orphan Drug with Untapped Potential 2023 ·Pharmaceuticals ·Emma Rybalka, (unknown), (unknown), Behzad Moghadaszadeh, Alan H. Beggs, Cara A. Timpani	7
6	Adenylosuccinic Acid Is a Non-Toxic Small Molecule In Vitro and In Vivo 2023 ·Pharmaceuticals ·Cara A. Timpani, (unknown), Emma Rybalka	1
7	Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences 2021 ·Journal of Cachexia Sarcopenia and Muscle ·Dean G. Campelj, Cara A. Timpani, Emma Rybalka	7
8	Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy 2020 ·Scientific Reports ·Cara A. Timpani, Craig A. Goodman, Christos G. Stathis, Jason D. White, Kamel Mamchaoui, Gillian Butler‐Browne, Nuri Gueven, Alan Hayes, Emma Rybalka	27
9	Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility? 2020 ·Pharmaceuticals ·(unknown), Cara A. Timpani, Judy B. de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalka	63
10	The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction 2020 ·Cancers ·Dean G. Campelj, Cara A. Timpani, Aaron C. Petersen, Alan Hayes, Craig A. Goodman, Emma Rybalka	12
11	Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy 2020 ·Redox Biology ·(unknown), Cara A. Timpani, Judy B. de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalka	36
12	Testosterone suppression does not exacerbate disuse atrophy and impairs muscle recovery that is not rescued by high protein 2020 ·Journal of Applied Physiology ·Erik D. Hanson, Andrew C. Betik, Cara A. Timpani, (unknown), Xinmei Zhang, Alan Hayes	9
13	Chemotherapeutic agents induce mitochondrial superoxide production and toxicity but do not alter respiration in skeletal muscle in vitro 2017 ·Mitochondrion ·Emma Rybalka, Cara A. Timpani, (unknown), (unknown), Kulmira Nurgali, Alan Hayes	14
14	BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice 2017 ·Frontiers in Pharmacology ·(unknown), Aaron C. Petersen, Cara A. Timpani, Dean G. Campelj, (unknown), Adam J. Trewin, Vanesa Stojanovska, Mathew Stewart, Alan Hayes, Emma Rybalka	37
15	Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy 2017 ·Orphanet Journal of Rare Diseases ·Cara A. Timpani, Alan Hayes, Emma Rybalka	18
16	Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? 2016 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), Cara A. Timpani, Kulmira Nurgali, Alan Hayes, Emma Rybalka	67
17	Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle 2016 ·Neurotherapeutics ·Cara A. Timpani, Adam J. Trewin, Vanesa Stojanovska, Ainsley M. Robinson, Craig A. Goodman, Kulmira Nurgali, Andrew C. Betik, Nigel K. Stepto, Alan Hayes, Glenn K. McConell, Emma Rybalka	30
18	Idebenone protects against chemotherapy-induced skeletal muscle wasting and mitochondrial dysfunction in mice 2015 ·Victoria University Research Repository (Victoria University) ·(unknown), Cara A. Timpani, Dean G. Campelj, Aaron C. Petersen, Alan Hayes, Emma Rybalka	1
19	Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology 2015 ·Medical Hypotheses ·Cara A. Timpani, Alan Hayes, Emma Rybalka	100
20	Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency 2014 ·PLoS ONE ·Emma Rybalka, Cara A. Timpani, Matthew B. Cooke, Andrew D. Williams, Alan Hayes	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact